CD68 Inflammation & Tumor Test | Lahalak Platform
A key diagnostic tool for assessing inflammatory response and rare tumors, helping determine phagocytic cell activity to understand chronic inflammation and neoplastic diseases.
Scientific name: Immunohistochemistry (IHC): CD68
This diagnostic package, based on immunohistochemistry, involves testing for a range of markers specific to phagocytic cells (macrophages) and other immune cells. The package primarily includes testing for CD68 (PG-M1), a potent cytoplasmic and membrane marker of phagocytic cells (macrophages/monocytes), as well as essential complementary markers:...
Included Services
- The CD68 (PG-M1) macrophage marker test is used to identify phagocytic cells.
- CD163 specific marker testing for accurate phagocytic differentiation.
- The additional marker Lysozyme was tested to confirm phagocytic/myelogenic activity.
- Consult a pathologist specializing in immunopathology or hematology for an interpretation of the overall results.
Medical Service Information
Conditions & Notices
- It requires the submission of a complete tissue block (paraffin block) of the suspected biopsy specimen.
- It is necessary to attach the initial pathology report along with a description of the lesion and the clinical complaint.
- The patient does not need to fast, as the sample is tissue-based.
- The completion time ranges from 5 to 10 working days.